Jiao Yang

1.6k total citations
36 papers, 896 citations indexed

About

Jiao Yang is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Jiao Yang has authored 36 papers receiving a total of 896 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 13 papers in Cancer Research and 12 papers in Molecular Biology. Recurrent topics in Jiao Yang's work include Breast Cancer Treatment Studies (10 papers), Breast Lesions and Carcinomas (5 papers) and Genetic factors in colorectal cancer (5 papers). Jiao Yang is often cited by papers focused on Breast Cancer Treatment Studies (10 papers), Breast Lesions and Carcinomas (5 papers) and Genetic factors in colorectal cancer (5 papers). Jiao Yang collaborates with scholars based in China and United States. Jiao Yang's co-authors include Meng Lv, Yanwei Shen, Zheling Chen, Shuting Li, Pan Li, Biyuan Wang, Yang Jin, Min Yi, Mengying Wang and Shuting Li and has published in prestigious journals such as PLoS ONE, Journal of Ethnopharmacology and International Journal of Environmental Research and Public Health.

In The Last Decade

Jiao Yang

34 papers receiving 892 citations

Peers

Jiao Yang
Jiao Yang
Citations per year, relative to Jiao Yang Jiao Yang (= 1×) peers Laia Bassaganyas

Countries citing papers authored by Jiao Yang

Since Specialization
Citations

This map shows the geographic impact of Jiao Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiao Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiao Yang more than expected).

Fields of papers citing papers by Jiao Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiao Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiao Yang. The network helps show where Jiao Yang may publish in the future.

Co-authorship network of co-authors of Jiao Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Jiao Yang. A scholar is included among the top collaborators of Jiao Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiao Yang. Jiao Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Yan, et al.. (2025). Invasive lobular carcinoma of the breast: metastatic patterns and treatment modalities—a review. Frontiers in Oncology. 15. 1631670–1631670.
2.
Yang, Jiao, Xing Zhang, Lian Duan, et al.. (2025). Association of plasma zinc and copper levels with mild cognitive impairment in patients with type 2 diabetes. Frontiers in Nutrition. 12. 1532080–1532080. 1 indexed citations
3.
Xu, Lingyan, et al.. (2024). P‐glycoprotein‐mediated herb–drug interaction evaluation between Tenacissoside G and paclitaxel. Biomedical Chromatography. 38(10). e5984–e5984. 1 indexed citations
4.
Sun, Lisha, et al.. (2024). Lower Visceral Fat is Related to Diabetic Peripheral Neuropathy. Diabetes Metabolic Syndrome and Obesity. Volume 17. 2967–2974. 3 indexed citations
5.
Zhou, Xiaoyu, et al.. (2023). The causal relationship between osteoarthritis and bladder cancer: A Mendelian randomization study. Cancer Medicine. 13(1). e6829–e6829. 6 indexed citations
6.
Yang, Jiao, Dan Li, Bo Jiang, et al.. (2022). Tongguanteng injection reverses paclitaxel resistance via upregulation of TAB1 expression in ovarian cancer in vitro and in vivo. Journal of Ethnopharmacology. 300. 115728–115728. 6 indexed citations
7.
Tian, Qi, Andi Zhao, Biyuan Wang, et al.. (2020). The role of adjuvant radiotherapy in patients with malignant phyllodes tumor of the breast: a propensity-score matching analysis. Breast Cancer. 28(1). 110–118. 11 indexed citations
8.
Yang, Jiao, Xiaoman Zhang, Zheling Chen, et al.. (2019). Angiomotin-p130 inhibits β-catenin stability by competing with Axin for binding to tankyrase in breast cancer. Cell Death and Disease. 10(3). 179–179. 14 indexed citations
9.
Yang, Jiao, Yanwei Shen, Biyuan Wang, et al.. (2019). Comparative Analysis of Outcomes and Clinicopathological Characteristics of Synchronous and Metachronous Contralateral Breast Cancer: A Study of the SEER Database. Journal of Breast Cancer. 22(2). 297–297. 10 indexed citations
10.
Yang, Jiao, et al.. (2019). The potential markers of endocrine resistance among HR+ /HER2+ breast cancer patients. Clinical & Translational Oncology. 22(4). 576–584. 15 indexed citations
11.
Li, Shuting, Jiao Yang, Yanwei Shen, et al.. (2019). Clinicopathological features, survival and risk in breast cancer survivors with thyroid cancer: an analysis of the SEER database. BMC Public Health. 19(1). 1592–1592. 16 indexed citations
12.
Chen, Zheling, Jiao Yang, Yanwei Shen, et al.. (2018). AmotP130 regulates Rho GTPase and decreases breast cancer cell mobility. Journal of Cellular and Molecular Medicine. 22(4). 2390–2403. 6 indexed citations
13.
Wang, Biyuan, Jiao Yang, Shuting Li, et al.. (2017). Tumor location as a novel high risk parameter for stage II colorectal cancers. PLoS ONE. 12(6). e0179910–e0179910. 24 indexed citations
14.
Chen, Zheling, Jiao Yang, Shuting Li, et al.. (2017). Invasive lobular carcinoma of the breast: A special histological type compared with invasive ductal carcinoma. PLoS ONE. 12(9). e0182397–e0182397. 107 indexed citations
15.
Li, Shuting, Jiao Yang, Meng Lv, et al.. (2017). Clinicopathological features and survival of early stage breast cancer in northwest China: A population‐based retrospective study of 1287 patients. Thoracic Cancer. 9(1). 10–18. 10 indexed citations
16.
Lv, Meng, Xiao Zhang, Yanwei Shen, et al.. (2017). Clinical analysis and prognosis of synchronous and metachronous multiple primary malignant tumors. Medicine. 96(17). e6799–e6799. 77 indexed citations
17.
Yang, Jiao, Shuting Li, Meng Lv, et al.. (2017). Risk of subsequent primary malignancies among patients with prior colorectal cancer: a population-based cohort study. OncoTargets and Therapy. Volume 10. 1535–1548. 13 indexed citations
18.
Yang, Jiao, Shuting Li, Biyuan Wang, et al.. (2016). Potential biomarkers for anti-EGFR therapy in metastatic colorectal cancer. Tumor Biology. 37(9). 11645–11655. 21 indexed citations
19.
Wang, Xin, Yanwei Shen, Shuting Li, et al.. (2016). Importance of the interaction between immune cells and tumor vasculature mediated by thalidomide in cancer treatment (Review). International Journal of Molecular Medicine. 38(4). 1021–1029. 19 indexed citations
20.
Fu, Jianfei, Hailong Chen, Jiao Yang, Chenghao Yi, & Shu Zheng. (2014). Feasibility and Accuracy of Sentinel Lymph Node Biopsy in Clinically Node-Positive Breast Cancer after Neoadjuvant Chemotherapy: A Meta-Analysis. PLoS ONE. 9(9). e105316–e105316. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026